The phase 3 SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) clinical trial program evaluated the efficacy and safety of semaglutide in subjects with T2D in a range of patient populations across the continuum of diabetes care [7,8,9,10,11,12,13,14]
Prolactinomas occur most often in women aged 20-50 years, but they can occur at any age
infection dampens NLRP3 activation by modulating mitochondrial ROS production, partly through upregulation of antioxidant enzymes such as superoxide dismutases (SOD1 and SOD2), catalase (CAT), and glutathione peroxidase (GPx)
( c ) Data represent mean normalized to Control-Ab for the corresponding route of administration
Comprehensive toxicology evaluation revealed no lethal dose in rats receiving up to 20 mg/kg intramuscularly with 14-day observation